Bourron Olivier

[Bourron Olivier @BourronO]

⬇️ glycemic criteria for the diagnosis of gestational diabetes (fasting glycemia 90 mg/dL or 2h glycemia 153mg/dL) did not result in a ⬇️ risk of a large-for-gestational-age infant than⬆️ glycemic criteria(fasting glycemia 99 mg/dL or 2h glycemia 162mg/dL) https://t.co/8t9fRwOTiV

[Bourron Olivier @BourronO]

This phenomapping-derived tool identified patient phenotypes with greater ASCVD canagliflozin effects (adjusted HR 0.60 [95% CI 0.41–0.89] vs. 0.99 [95% CI 0.76–1.29]; Pinteraction = 0.04). (3/3)

[Bourron Olivier @BourronO]

Machine learning–guided algorithm to personalize the prescription of #SGLT2 inhibitors for patients with type 2 #diabetes for #ASCVD effects. #Canagliflozin #cardiovascular #Risk #T2D (1/3) https://t.co/oYI75wYRiN

[Bourron Olivier @BourronO]

A 15-variable tool (#retinopathy, #neuropathy, #coronaropathy, #HF, #male, #smoking, #dyslipidemia #hypertension, ⬆️#HDL, #BMI, ⬆️#creatinine, ⬇️DFG, ethny) predict the personalized ASCVD effects of canagliflozin (2/3)